We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The effect of ITF-1697 on reperfusion in patients undergoing primary angioplasty.
- Authors
Dirksen, Maurits T; Laarman, GertJan; van ‘t Hof, Arnoud W.J; Guagliumi, Giulio; Tonino, Wilhelmus A.L; Tavazzi, Luigi; Duncker, Dirk J.G.M; Simoons, Maarten L
- Abstract
Aim ITF-1697 is a C-reactive protein-derived tetrapeptide that, based on pre-clinical studies, is thought to reduce reperfusion injury. We performed a dose-finding study to assess safety, preliminary efficacy and clinical outcome of prolonged i.v. infusion of ITF-1697 in patients with an acute myocardial infarction (AMI) who were eligible for percutaneous coronary intervention (PCI).
- Publication
European Heart Journal, 2004, Vol 25, Issue 5, p392
- ISSN
0195-668X
- Publication type
Article
- DOI
10.1016/j.ehj.2003.12.018